
Injective (INJ) rises 10% on strong buying, ETF hopes, and updated white paper news
Injective (INJ) surged 10% amid increased buying pressure and notable exchange outflows, signaling renewed trader interest. Positive funding rates and rising open interest indicate bullish positioning, while ongoing ETF applications and an updated wh...





